Buas, Matthew F.
Gu, Haiwei
Djukovic, Danijel
Zhu, Jiangjiang
Onstad, Lynn
Reid, Brian J.
Raftery, Daniel
Vaughan, Thomas L.
Funding for this research was provided by:
National Cancer Institute (R21CA178621)
National Cancer Institute (T32CA009168, K05CA124911, P01CA091955, 5P30CA015704)
Article History
Received: 29 June 2016
Accepted: 16 December 2016
First Online: 20 January 2017
Compliance with ethical standards
:
: D.R. holds equity and an executive role in Matrix‑Bio, Inc. (IN, USA). The authors have no other potential conflicts of interest to disclose.
: All authors complied with ethical policies as described. Potential conflicts of interests were disclosed. This study included human participants and was approved by the Institutional Review Board at the Fred Hutchinson Cancer Research Center. Appropriate informed consent was obtained.